Inventor

David C. Cipolla

Inventor
San Ramon, CA, US

Overview

21→
Patents
1995–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
Y02ATechnologies for adaptation to climate change15%
C07KPeptides6%
A24DCigars2%
A61MDevices for introducing media into, or onto, the body2%
B01DSeparation2%
C12NMicroorganisms or enzymes2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
11,116,765Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria202111,026,941Concentrated, inhalable ciprofloxacin formulation202110,420,765Concentrated, inhalable ciprofloxacin formulation201910,376,508Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria20199,987,227Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile20189,968,555Liposomal formulations that form drug nanocrystals after freeze-thaw20189,844,548Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals20179,545,401'Concentrated, inhalable ciprofloxacin formulation'20179,532,986'Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria'20179,259,424'Concentrated, inhalable antibiotic formulation'20169,078,897'Concentrated, inhalable antibiotic formulation'20159,028,864'Concentrated, inhalable antibiotic formulation'20158,414,915'Dual action, inhaled formulations providing both an immediate and sustained release profile'20138,268,347'Dual action, inhaled formulations providing both an immediate and sustained release profile'20128,119,156'Dual action, inhaled formulations providing both an immediate and sustained release profile'20128,071,127'Dual action, inhaled formulations providing both an immediate and sustained release profile'20115,945,402'Human relaxin formulation'19995,829,435'Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles'19985,770,152'Collapsible container for measuring particles in a sample fluid'19985,457,044'Method for collection of aerosolized proteins by inert filtration'19955,451,572'Human relaxin formulation'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1999Patents assigned to GENENTECH INC (3)· patent assignee history
1995–1999Based in Danville, CA, US· patent location history
1995Based in San Francisco, CA, US· patent location history
1998–2019Patents assigned to ARADIGM CORP (16)· patent assignee history
1998Based in Belmont, CA, US· patent location history
2011–2017Patents assigned to BLANCHARD JAMES (6)· patent assignee history
2011–2017Patents assigned to CIPOLLA DAVID C (6)· patent assignee history
2011–2021Based in San Ramon, CA, US· patent location history
2021Patents assigned to GRIFOLS SA (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARADIGM CORP161998–2019
BLANCHARD JAMES62011–2017
CIPOLLA DAVID Cself62011–2017
GENENTECH INC31995–1999
GRIFOLS SA22021
Locations
LocationPatentsSpan
San Ramon, California, US162011–2021
Danville, California, US21995–1999
Belmont, California, US21998
San Francisco, California, US11995